DAY THREE: 03 JuneMedicinal Chemistry and Optimisation of HITs
Learn from experts in overcoming major bottleneck in drug discovery projects in the optimization of hits from screening. Case studies include innovative molecular drug design methods as well as in the integration Of DEL, Covalent Inhibitors and Protein Degradation Technologies In The Optimization Of HITs
Agenda at a Glance
Stream 1: Integration Of Technologies In The Optimization Of HITs – DEL, Covalent Inhibitors and Protein Degradation
Stream 2: Molecular Drug Design and Medicinal Chemistry
Afternoon Interactive Roundtable Sessions:
- New Chemical Modalities And Challenging Targets (Small And Large Molecules) And Choice Of Modalities
- Covalent Inhibitors Design and Discovery – Overcoming Challenges
Day Three Key Speakers include
Werngard Czechtizky
AstraZeneca
Rolf Jautelat
Bayer AG
Carl Petersson
Merck KGaA
Phil Cox
AbbVie
Jake Wiener
Lumbeck